Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 91501-91550 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT05195060
TURN-COVID Biobank: The Dutch Cohort Study for the Evaluation of the Use of Neutralizing Monoclonal Antibodies and Other Antiviral Agents Against SARS-CoV-2
N/ARecruiting
1,000 participants
Started: Dec 14, 2021 · Completed: Jun 14, 2024
1 condition1 sponsor4 locations
NCT05070858
A Study to Test How Safe Pozelimab and Cemdisiran Combination Therapy and Cemdisiran Alone Are and How Well They Work in Adult Patients With Generalized Myasthenia Gravis
PHASE3Active, not recruiting
288 participants
Started: Dec 14, 2021 · Completed: Nov 11, 2028
1 condition1 sponsor116 locations
NCT05578586
A Pilot Study for Optimizing Meropenem Administration in the ICU
NARecruiting
50 participants
Started: Dec 14, 2021 · Completed: Jun 30, 2027
1 condition1 sponsor1 location
NCT04731844
Curcumin and Piperine in Patients on Surveillance for Monoclonal Gammopathy, Smoldering Myeloma or Prostate Cancer
PHASE2Recruiting
40 participants
Started: Dec 14, 2021 · Completed: May 31, 2025
4 conditions1 sponsor1 location
NCT03567213
Investigation on the Cortical Communication (CortiCom) System
NARecruiting
3 participants
Started: Dec 14, 2021 · Completed: Aug 31, 2026
4 conditions2 sponsors1 location
NCT05607303
Effect of Hormones on Frequency of Headache and Brain Structure and Function in Puberty
N/AActive, not recruiting
140 participants
Started: Dec 14, 2021 · Completed: Jun 30, 2026
2 conditions1 sponsor1 location
NCT05177809
RFC1 Natural History Study
N/ARecruiting
150 participants
Started: Dec 14, 2021 · Completed: Dec 31, 2025
1 condition1 sponsor10 locations
NCT04947059
Effectiveness of an Immediate Postoperative Intravesical Instillation With Either Gemcitabine or Epirubicin in Patients With Urinary Bladder Cancer (Gemcitabine Epirubicin Normal SAline)
PHASE3Recruiting
180 participants
Started: Dec 14, 2021 · Completed: Oct 31, 2026
1 condition1 sponsor1 location
NCT05176483
Study of XL092 in Combination With Immuno-Oncology Agents in Subjects With Solid Tumors
PHASE1Active, not recruiting
1,274 participants
Started: Dec 14, 2021 · Completed: Jun 28, 2030
8 conditions1 sponsor122 locations
NCT06598605
An Intervention Program to Improve Emotion Regulation Among Parents of Children with ASD
NAActive, not recruiting
200 participants
Started: Dec 14, 2021 · Completed: Nov 30, 2024
1 condition1 sponsor1 location
NCT05341739
A Phase II Study of Pre-Op SRS Followed by Surgical Resection for Brain Metastases
NAActive, not recruiting
20 participants
Started: Dec 14, 2021 · Completed: Nov 30, 2025
1 condition2 sponsors1 location
NCT05136352
Postoperative Analgesic Benefit of iPACK Block in the Anterior Cruciate Ligament Reconstruction Surgery
NAActive, not recruiting
90 participants
Started: Dec 13, 2021 · Completed: Dec 31, 2023
2 conditions1 sponsor1 location
NCT03587532
Assessment of Graft Perfusion and Oxygenation for Improved Outcome in Esophageal Cancer Surgery
NARecruiting
70 participants
Started: Dec 13, 2021 · Completed: Dec 31, 2024
2 conditions2 sponsors1 location
NCT05042687
Comparative Performance of Molecular Breast Imaging (MBI) to Magnetic Resonance Imaging (MRI) of the Breast in Identifying and Excluding Breast Carcinoma in Women at High Risk for Breast Cancer
NARecruiting
300 participants
Started: Dec 13, 2021 · Completed: Dec 31, 2027
1 condition1 sponsor1 location
NCT05494073
Anterior Cruciate Ligament Reconstruction Hybrid Remnant Repair
NAActive, not recruiting
100 participants
Started: Dec 13, 2021 · Completed: Nov 30, 2026
1 condition1 sponsor1 location
NCT04908228
Fixed-duration Therapy With Ibrutinib and Obinutuzumab (GA-101) in Treatment-naïve Patients With CLL
PHASE2Recruiting
53 participants
Started: Dec 13, 2021 · Completed: Sep 15, 2027
1 condition1 sponsor1 location
NCT05180474
GEN1047 for Solid Tumors - First in Human (FIH) Trial
PHASE1/PHASE2Active, not recruiting
179 participants
Started: Dec 13, 2021 · Completed: Mar 26, 2026
4 conditions1 sponsor36 locations
NCT04988074
Trial of Cemiplimab, or Cemip-Chemo Followed by Biomarker-guided Treatment for Pts w/HPV H&N Ca
PHASE2Recruiting
32 participants
Started: Dec 13, 2021 · Completed: Aug 31, 2026
1 condition2 sponsors1 location
NCT05116189
Pembrolizumab/Placebo Plus Paclitaxel With or Without Bevacizumab for Platinum-resistant Recurrent Ovarian Cancer (MK-3475-B96/KEYNOTE-B96/ENGOT-ov65)
PHASE3Active, not recruiting
643 participants
Started: Dec 13, 2021 · Completed: Oct 25, 2028
3 conditions1 sponsor187 locations
NCT05167487
Pathological Response After Neoadjuvant Treatment on NSCLC
N/ARecruiting
150 participants
Started: Dec 13, 2021 · Completed: Dec 1, 2025
1 condition1 sponsor17 locations
NCT04261413
Phase Ia/Ib Study of RS-0139 in Patients with a Recurrent, Locally Advanced or Metastatic Solid Tumors
PHASE1Recruiting
16 participants
Started: Dec 13, 2021 · Completed: Dec 31, 2025
1 condition1 sponsor2 locations
NCT05064891
Ultrasound Application on the Suprascapular Nerve and Dynamic Shoulder Movement for Stroke Patients
N/AEnrolling by invitation
200 participants
Started: Dec 13, 2021 · Completed: Jul 1, 2026
1 condition1 sponsor1 location
NCT05241210
Real-Time Feedback (RTFB) to Improve Colonoscopy
NARecruiting
4,150 participants
Started: Dec 13, 2021 · Completed: Jun 15, 2025
1 condition3 sponsors3 locations
NCT04573140
A Study of RNA-lipid Particle (RNA-LP) Vaccines for Newly Diagnosed Pediatric High-Grade Gliomas (pHGG) and Adult Glioblastoma (GBM)
PHASE1Recruiting
28 participants
Started: Dec 13, 2021 · Completed: Jul 1, 2029
3 conditions7 sponsors1 location
NCT05163028
A Dose Escalation Study of SHP2 Inhibitor in Patients With Solid Tumors Harboring KRAS of EGFR Mutations
PHASE1Active, not recruiting
42 participants
Started: Dec 13, 2021 · Completed: Dec 31, 2026
7 conditions1 sponsor12 locations
NCT05139836
A Study to Assess Disease Activity in Adolescent and Adult Participants With Atopic Dermatitis Who Receive Oral Upadacitinib Tablets in a Real-World Setting
N/AActive, not recruiting
634 participants
Started: Dec 13, 2021 · Completed: Sep 30, 2027
1 condition1 sponsor125 locations
NCT05295407
Performance of Inherited Risk Assessment for Predicting Prostate Cancer From Prostate Biopsy
N/ARecruiting
1,000 participants
Started: Dec 13, 2021 · Completed: Dec 13, 2025
1 condition4 sponsors1 location
NCT05020912
Alteration of the Immune Microenvironment in Basal Cell Carcinoma Following Photodynamic Therapy
PHASE2Recruiting
28 participants
Started: Dec 13, 2021 · Completed: Dec 31, 2027
1 condition1 sponsor1 location
NCT04982393
BONAPH1DE, A Prospective Observational Study of Patients With Primary Hyperoxaluria Type 1 (PH1)
N/ARecruiting
200 participants
Started: Dec 13, 2021 · Completed: Sep 1, 2028
1 condition1 sponsor30 locations
NCT04166071
Opioids and Social Support Enhanced Extinction Effects
EARLY_PHASE1Enrolling by invitation
60 participants
Started: Dec 13, 2021 · Completed: Sep 30, 2026
1 condition2 sponsors2 locations
NCT06698913
Feasibility and Efficacy of Automated Lateral Decubitus Therapy in Hypoxemic Respiratory Failure
NAActive, not recruiting
80 participants
Started: Dec 13, 2021 · Completed: Dec 31, 2025
4 conditions1 sponsor1 location
NCT05169580
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Pociredir
PHASE1Recruiting
70 participants
Started: Dec 13, 2021 · Completed: Dec 31, 2025
2 conditions1 sponsor23 locations
NCT04852198
Comparing 150cm OAGB With 150cm Biliopancreatic Limb RYGB. A Non-inferiority Trial
NARecruiting
298 participants
Started: Dec 13, 2021 · Completed: Nov 1, 2029
3 conditions1 sponsor2 locations
NCT05156281
Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS)
PHASE3Recruiting
800 participants
Started: Dec 13, 2021 · Completed: Oct 30, 2030
1 condition1 sponsor246 locations
NCT04925154
Tradeoffs in Patient Decision Making About Rectal Cancer Treatment: Benefits Compared to Quality Of Life.
N/ARecruiting
192 participants
Started: Dec 13, 2021 · Completed: Jan 1, 2026
1 condition1 sponsor1 location
NCT05144152
Diagnostic Accuracy of M3 in Predicting Colorectal Advanced Adenoma Recurrence (M3-AA)
N/ARecruiting
600 participants
Started: Dec 13, 2021 · Completed: Jun 15, 2025
3 conditions1 sponsor1 location
NCT05022654
SI-B001 Combined With Irinotecan in the Treatment of Recurrent Metastatic Esophageal Squamous Cell Carcinoma.
PHASE2Active, not recruiting
22 participants
Started: Dec 13, 2021 · Completed: Dec 31, 2025
1 condition1 sponsor6 locations
NCT05272462
Oral Minoxidil for the Treatment of Recurrent Platinum Resistant Epithelial Ovarian Cancer
PHASE2Recruiting
34 participants
Started: Dec 13, 2021 · Completed: Dec 31, 2024
1 condition3 sponsors1 location
NCT04177511
Treatment of Chronic Pelvic Pain Due to Endometriosis by Transcutaneous Auricular Vagus Nerve Stimulation
NARecruiting
72 participants
Started: Dec 13, 2021 · Completed: Apr 30, 2025
1 condition1 sponsor1 location
NCT04741945
Repurposing Metformin As a Leukemia-preventive Drug in CCUS and LR-MDS
PHASE2Recruiting
40 participants
Started: Dec 13, 2021 · Completed: Feb 28, 2026
4 conditions8 sponsors1 location
NCT06329726
Long-Term Behavioral and Cognitive Outcomes of Deep Brain Stimulation in Patients With Parkinson's Disease
N/ARecruiting
52 participants
Started: Dec 13, 2021 · Completed: Dec 15, 2032
1 condition1 sponsor1 location
NCT05182892
REducing SPEECH-related Side-effects of Deep Brain Stimulation in Parkinson's Disease Via Automated Speech Analysis
NARecruiting
45 participants
Started: Dec 13, 2021 · Completed: Feb 28, 2026
1 condition2 sponsors2 locations
NCT04251351
Effect of Paracetamol on Kidney Function in Severe Malaria
PHASE3Recruiting
460 participants
Started: Dec 13, 2021 · Completed: Nov 1, 2025
4 conditions3 sponsors1 location
NCT05051436
The Effects of Mirabegron and Tadalafil on Glucose Tolerance in Prediabetics
PHASE4Recruiting
96 participants
Started: Dec 13, 2021 · Completed: Jan 31, 2026
2 conditions2 sponsors1 location
NCT04928261
Evaluating 6-months of HER2-targeted Therapy in Patients With HER2 Positive Early-stage Breast Cancer That Achieve a Pathological Complete Response to Neoadjuvant Systemic Therapy
PHASE4Recruiting
50 participants
Started: Dec 13, 2021 · Completed: Dec 31, 2028
1 condition1 sponsor1 location
NCT05822089
Intraindividual Comparison of EMO IOLs
NARecruiting
311 participants
Started: Dec 13, 2021 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT05071144
Spine Procedures Assisted With RoboTics And Navigation
N/ARecruiting
600 participants
Started: Dec 13, 2021 · Completed: Dec 31, 2031
6 conditions11 sponsors9 locations
NCT06179251
KNOW HOW TO POSITION THE SACCULE AND UTRICULE IN SCANNING
N/ARecruiting
40 participants
Started: Dec 13, 2021 · Completed: Dec 31, 2023
1 condition1 sponsor1 location
NCT05316922
TSH Suppression During Radiotherapy on Thyroid Site to Prevent Iatrogenic Hypothyroidism in Pediatric Cancer Patients
PHASE3Recruiting
68 participants
Started: Dec 13, 2021 · Completed: Sep 30, 2029
1 condition1 sponsor1 location
NCT05114876
Redesigning the Surgical Pathway (PROMoTE)
NARecruiting
260 participants
Started: Dec 13, 2021 · Completed: Dec 31, 2025
5 conditions1 sponsor1 location